Clinical Study

The Metabolic Syndrome among Postmenopausal Women in Gorgan

Table 1

Baseline data of postmenopausal women (total subjects and subjects with and without metabolic syndrome).

ParametersTotal number of postmenopausal womenPostmenopausal women with metabolic syndromePostmenopausal women without metabolic syndrome value

All women, no. (%)1003169
Age (years)54.32 ± 5.2654.51 ± 5.3154.31 ± 5.390.865
Years since menopause5.36 ± 3.385.0 ± 3.545.62 ± 3.370.403
BMI, kg/m230.98 ± 5.5233.68 ± 5.4029.77 ± 5.170.001
WC, cm91.12 ± 11.7097.98 ± 9.4788.04 ± 11.34<0.001
Hip circumference, cm104.61 ± 9.23109.03 ± 10.43102.62 ± 7.950.001
WHR0.87 ± 0.090.89 ± 0.070.84 ± 0.130.030
SBP, mmHg150.23 ± 17.02160.0 ± 20.45135.32 ± 1.830.505
DBP, mmHg78.72 ± 1.2483.61 ± 1.1076.52 ± 1.250.008
FBS, mg/dL107.66 ± 63.53143.45 ± 100.3891.57 ± 24.170.008
TG, mg/dL122.94 ± 91.67171.90 ± 124.20100.94 ± 62.0<0.001
T-Chol, mg/dL210.87 ± 49.28219.71 ± 49.80206.90 ± 48.880.231
HDL-Chol, mg/dL46.49 ± 14.2342.54 ± 8.6048.26 ± 15.860.022
LDL-Chol, mg/dL129.32 ± 40.52128.32 ± 44.23129.77 ± 39.070.870

BMI: body mass index, WC: waist circumference, WHR: waist-to-hip ratio, SBP: systolic blood pressure, DBP: diastolic blood pressure, FBS: fasting blood glucose, TG: triglyceride, T-CHOL: total cholesterol, HDL-CHOL: HDL-cholesterol, and LDL-CHOL: LDL-cholesterol.